MedicalXpress reports that University of Manchester Cancer Research UK, Manchester Institute researchers demonstrated that a small volume of blood can contain up-to-date genetic information about a patient’s cancer to inform treatment choices.  In the first of two-part trial called TARGET, the researchers were able to collect, process and analyze blood samples from 100 patients in the Manchester, UK, area. In this feasibility study, 11 were enrolled on an available and molecularly matched clinical trial.

Lead Research/Investigator

Caroline Dive

Source: medicalxpress

Pin It on Pinterest